Helena Dzojic

Adenovirus CD40 Ligand Gene Therapy Counteracts Immune Escape Mechanisms in the Tumor Microenvironment

Angelica Loskog, Helena Dzojic, Sofia Vikman et al. · The Journal of Immunology · 2004 · 77 citations · Full text

Medicine, Immunology, Oncology +17

An oncolytic conditionally replicating adenovirus for hormone-dependent and hormone-independent prostate cancer

W-S Cheng, Helena Dzojic, Bo Nilsson et al. · Cancer Gene Therapy · 2005 · 41 citations

Medicine, Molecular Biology, Oncology +11

A Novel Chromogranin-A Promoter-Driven Oncolytic Adenovirus for Midgut Carcinoid Therapy

Justyna Leja, Helena Dzojic, Elisabet Gustafson et al. · Clinical Cancer Research · 2007 · 41 citations

Life Sciences, Molecular Biology, Oncology +13

Increased therapeutic efficacy of the prostate-specific oncolytic adenovirus Ad[I/PPT-E1A] by reduction of the insulator size and introduction of the full-length E3 region

Anna Danielsson, Helena Dzojic, Bo Nilsson et al. · Cancer Gene Therapy · 2008 · 37 citations

Medicine, Cancer Biology, Oncology +12

Adenovirus‐mediated CD40 ligand therapy induces tumor cell apoptosis and systemic immunity in the TRAMP‐C2 mouse prostate cancer model

Helena Dzojic, Angelica Loskog, Thomas H. Tötterman et al. · The Prostate · 2006 · 35 citations

Life Sciences, Immunology, Oncology +17